Dr. Michael Derek Westafer, MD

Dr. Westafer practices at Sierra Nevada Eye Center in Reno, Nevada.

Dr. Westafer's NPI, 1033473913, was assigned on June 26, 2012. Dr. Westafer graduated from University of North Carolina School of Medicine in 2012. Dr. Westafer holds Nevada license 17065.

Dr. Westafer's primary practice is Sierra Nevada Eye Center, at 9468 Double R Blvd, Reno, NV 89521 in Washoe County. The practice phone is (775) 841-2000.

Dr. Westafer's primary practice is Sierra Nevada Eye Center in Reno, Nevada. Dmand AI also links Dr. Westafer to 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Westafer practices. Vendor and product names are available with a free account.

Ophthalmology is Dr. Westafer's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Westafer is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Westafer's licenses on file in 3 states: Nevada, California and Ohio.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, conjunctivitis, dry eye, eyelid inflammation, glaucoma and glaucoma surgery among the conditions Dr. Westafer treats.

CMS data shows 5,106 Medicare services from Dr. Westafer across 24 procedure codes in 2024, for 1,143 Medicare patients. Medicare paid $367,504 for them.

CMS counts 1,143 Medicare patients who saw Dr. Westafer in 2024. The largest group is 75 to 84, with 503 patients. 75% of them have high cholesterol, and 63% have high blood pressure. 5% are also on Medicaid. Their average risk score is 1.00, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Westafer's median patient age at 74, with 54% women.

In 2024, Dr. Westafer wrote 5,778 Medicare Part D claims for 1,091 patients. 67% of them were for generic drugs. CMS names the drug for 5,688 of them, across 30 drugs with 11 or more claims each, at $504,811 in total drug cost. In 2023, CMS named 5,235 claims across 28 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Westafer for performance year 2024, reported as part of a group. Dr. Westafer accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 289 procedures of cataract surgery by Dr. Westafer, more than 89% of the clinicians it reports for that procedure.

CMS Open Payments shows 139 general payments to Dr. Westafer from 27 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Alcon Laboratories Inc paid the most, $1,241.

Dr. Westafer graduated from University of North Carolina School of Medicine in 2012. Dr. Westafer is a member of AAO.

Dr. Westafer is in network with 17 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.